TNF and rheumatoid arthritis: In our previous study, we demonstrated that repeated infusions of the chimeric anti-TNF-α monoclonal antibody (infliximab), beside the decrease in RA activity, reduce serum levels of MMP-1, MMP-3 and MMP-9 [13].